Chinese Translations

Neurology® 2016; Vol. 86

Systemic right-to-left shunts, ischemic brain lesions, and persistent migraine activity, Koppen et al. 86(18):1668-1675

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy, Devaux et al. 86(9):800-807

How common are ALS plateaus and reversals?, Bedlack et al. 86(9):808-810

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort, Murphy et al. 86(9):813-820

Increased CSF neurogranin concentration is specific to Alzheimer disease, Wellington et al. 86(9):829-835

Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study, Tsai et al. 86(9):840-846

Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy, van Veluw et al. 86(9):867-871

Acute bulbar palsy as a variant of Guillain-Barré syndrome, Kim et al. 86(8):742-747

GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up, Odekerken et al. 86(8):755-761

Effect of endovascular reperfusion in relation to site of arterial occlusion, Lemmens et al. 86(8):762-770

Recognizing and preventing epilepsy-related mortality: A call for action, Devinsky et al. 86(8):779-786

Vascular factors in suspected normal pressure hydrocephalus: A population-based study, Jaraj et al. 86(7):592-599

Association of arterial stiffness with progression of subclinical brain and cognitive disease, Tsao et al. 86(7):619-626

Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions, Kim et al. 86(7):627-636

Whole-brain MRI phenotyping in dysplasia-related frontal lobe epilepsy, Hong et al. 86(7):643-648

Ocular vestibular evoked myogenic potentials as a test for myasthenia gravis, Valko et al. 86(7):660-668

National characteristics and predictors of neurologic 30-day readmissions, Guterman et al. 86(7):669-675

Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: A pooled analysis, Johansson et al. 86(6):498-504

White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy, Charidimou et al. 86(6):505-511

Early- vs late-onset subcortical vascular cognitive impairment, Jang et al. 86(6):527-534

Real-time effects of centrotemporal spikes on cognition in rolandic epilepsy: An EEG-fMRI study, Xiao et al. 86(6):544-551

Change in brain network connectivity during PACAP38-induced migraine attacks: A resting-state functional MRI study, Amin et al. 86(2):180-187

Relationship of regional brain β-amyloid to gait speed, del Campo et al. 86(1):36-43

Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study, Zwan et al. 86(1):50-58

Time trends in causes of death after aneurysmal subarachnoid hemorrhage: A hospital-based study, Vergouwen et al. 86(1):59-63

Medical vs invasive therapy in AVM-related epilepsy: Systematic review and meta-analysis, Josephson et al. 86(1):64-71

 

Neurology® 2015; Vol. 85

IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry, Mazya 85(24):2098-2106

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort, Gijselinck et al. 85(24):2116-2125

Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2), Heatwole et al. 85(24):2136-2146

Early radiosurgery provides superior pain relief for trigeminal neuralgia patients, Mousavi et al. 85(24):2159-2165

Tilt-induced vasovagal syncope and psychogenic pseudosyncope: Overlapping clinical entities, Blad et al. 85(23):2006-2010

Disruption of posteromedial large-scale neural communication predicts recovery from coma, Silva et al. 85(23):2036-2044

Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage, Wu et al. 85(23):2045-2052

Arterial ischemic stroke in children with cardiac disease, Asakai et al. 85(23):2053-2059

Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology, Halperin et al. 85(23):2063-2071

Amyloid burden and sleep blood pressure in amnestic mild cognitive impairment, Tarumi et al. 85(22):1922-1929

Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons, Boyle et al. 85(22):1930-1936

Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study, Mawet et al. 85(22):1945-1949

Moderate alcohol intake reduces risk of ischemic stroke in Korea, Lee et al. 85(22):1950-1956

Quality of life in patients with TIA and minor ischemic stroke, Sangha et al. 85(22):1957-1963

Endovascular vs medical management of acute ischemic stroke, Chen et al. 85(22):1980-1990

Registration status and outcome reporting of trials published in core headache medicine journals, Rayhill et al. 85(20): 1789-1794

Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study, Li et al. 85(17): 1444-1451

Migraine and risk of stroke in older adults: Northern Manhattan Study, Monteith et al. 85(8): 715-721

 

Neurology® 2015; Vol. 84

Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants, Malik et al. 84(21): 2132-2145

Reduced efficacy of sumatriptan in migraine with aura vs without aura, Hansen et al. 84(18): 1880-1885

Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine, Lipton et al. 84(7): 688-695

 

Recalled maltreatment, migraine, and tension-type headache: Results of the AMPP Study, Tietjen et al. 84(2): 132-140

Quality improvement in neurology: Primary headache quality measures, Ross et al. 84(2): 200-203

 

Neurology® 2014; Vol. 83

How transparent are migraine clinical trials?: Repository of Registered Migraine Trials (RReMiT), Dufka et al. 83(15): 1372-1381

Midlife migraine and late-life parkinsonism: AGES-Reykjavik Study, Scher et al. 83(14): 1246-1252

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention, Ho et al. 83(11): 958-966

 

Neurology® 2014; Vol. 82

Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine, Ho et al. 82(11): 976-983

 

Neurology® 2013; Vol. 81

Prevalence of white matter lesions and stroke in children with migraine, Mar et al. 81(16): 1387-1391

Migraine and white matter hyperintensities: The ARIC MRI study, Hamedani et al. 81(15): 1308-1313

Migraine and structural changes in the brain: A systematic review and meta-analysis, Bashir et al. 81(14): 1260-1268

 

Neurology® 2013; Vol. 80

Migraine, depression, and brain volume: The AGES-Reykjavik Study, Gudmundsonn et al. 80(23): 2138-2144

 

Neurology® 2012; Vol. 79

Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study, Postuma et al. 79(5):428-434

GBA-associated PD: Neurodegeneration, altered membrane metabolism, and lack of energy failure, Brockmann et al. 79(3):213-220

Networks involved in seizure initiation: A reading epilepsy case studied with EEG-fMRI and MEG, Vaudano et al. 79(3):249-253

A new early and automated MRI-based predictor of motor improvement after stroke, Granziera et al. 79(1):39-46

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease, Lattante et al. 79(1):66-72

Early-onset Alzheimer disease clinical variants: Multivariate analyses of cortical thickness, Ridgway et al. 79(1):80-84

 

Neurology® 2012; Vol. 78

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease, Knopman et al. 78(20):1576-1582

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society, Silberstein et al. 78(17):1337- 1345

Staging and natural history of cerebrovascular pathology in dementia, Deramecourt et al. 78(14):1043-1050

Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Patwa et al. 78(13):1009-1015

Clinical Reasoning: A 33-year-old woman with severe postpartum occipital headaches, Maalouf and Harik 78(5):366-369

Comparative efficacy of combination drug therapy in refractory epilepsy, Poolos et al. 78(1):62-68

 

Neurology® 2011; Vol. 77

Effects of β-blocker selectivity on blood pressure variability and stroke: A systematic review, Webb et al. 77(8):731-737

Late-onset lower motor neuronopathy: A new autosomal dominant disorder, Jokela et al. 77(4):334-340

 

Neurology® 2011; Vol. 76

Demographic and clinical characteristics of malignant multiple sclerosis, Gholipour et al. 76(23):1996-2001

Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation, Bril et al. 76(20):1758-1765

Early recognition of poor prognosis in Guillain-Barr¨¦ syndrome, Walgaard 76(11):968-975

Clinical Reasoning: A rare cause of subarachnoid hemorrhage, Enami et al. 76(11):e43-e47

Guillain-Barré syndrome and SIADH, Saifudheen et al. 76(8):701-704

A Tale of Two Tauopathies, Hawley et al. 76(7 Supplement 2):S67-S71

Metabolic syndrome and cognitive decline in French elders: The Three-City Study, Raffaitin et al. 76(6):518-525

Clinical phenotypes in autopsy-confirmed Pick disease, Piguet et al. 76(3)253-259

Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Cortese et al. 76(3):294-300

Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort, Kim et al. 76(1):69-79

 

Neurology® 2010; Vol. 75

Acute and preventive pharmacologic treatment of cluster headache, Francis et al. 75(5):463-473

Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Schellinger et al. 75(2):177-185

Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment, Dotson et al. 75(1):27-34

 

Neurology® 2010; Vol. 74

New perspectives in the natural history of multiple sclerosis, Tremlett et al. 74(24):2004-2015

Clinical Reasoning: A 9-year-old girl with seizures and encephalopathy, Nguyes and El-Hakam 74(22):e97-e100

Distinguishing acute-onset CIDP from fluctuating Guillain-Barr¨¦ syndrome: A prospective study, Ruts et al. 74(21):1680-1686

Clinical staging and disease progression in frontotemporal dementia, Mioshi et al. 74(20):1591-1597

Clinical Reasoning: A 59-year-old man who became lost in his own home, Mondon et al. 74(16):e66-e68

Equipoise among recanalization strategies, Tomsick et al. 74(13):1069-1076

Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology, Zesiwicz et al. 74(11):924-931

Assessment: Symptomatic Treatment for Muscle Cramps (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of The American Academy of Neurology, Katzberg et al. 74(8):691-696

Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients, Feng et al. 74(7):588-593

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization, Petersen et al. 74(3):201-209

Assessment: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Dubinsky and Miyasaki 74(2):173-176

 

Neurology® 2009; Vol. 73

The natural history of primary progressive multiple sclerosis, Koch et al. 73(23):1996-2002

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Teunissen et al. 73(22):1914-1922

Effect of neutralizing antibodies on biomarker responses to interferon beta: The INSIGHT study, Pachner et al. 73(18):1493-1500

A 74-year-old woman with progressive right-hand tremor and inability to use her right side, Kertesz et al. 73(17):1399-1405

Relationships between biomarkers in aging and dementia, Jagust et al. 73(15):1193-1199

Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Miller et al. 73(15):1227-1233

Good clinical outcome after ischemic stroke with successful revascularization is time-dependent, Khatri et al. 73(13)1066-1072

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months, Llufriu et al. 73(12):949-953

The challenge of follow-on biologics for treatment of multiple sclerosis, Reingold et al. 73(7):552-559

Lifespan influences on mid- to late-life cognitive function in a Chinese birth cohort, Zhang et al. 73(3):186-194

Course in Parkinson disease subtypes: A 39-year clinicopathologic study, Rajput et al. 73(3):206-212

Clinical Reasoning:: A 22-year-old woman with headache and diplopia, Kim 73(1)e1-e7

 

Neurology® 2009; Vol. 72

Predictors of maintaining cognitive function in older adults: The Health ABC Study, Yaffe et al. 72(23):2029-2035

Population-based study of risk and predictors of stroke in the first few hours after a TIA, Chandratheva et al. 72(22):1941-1947

Invited Article: Human natural autoantibodies in the treatment of neurologic disease, Rodriguez et al. 72(14)1269-1276

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease, van der Vlies et al. 72(12):1056-1061

A controlled trial of antidepressants in patients with Parkinson disease and depression, Menza et al. 72(10)886-892

Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window, Parsons et al. 72(10)915-921

Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: A meta-analysis, van der Bilt et al. 72(7):635-642

When and how should treatment be started in Parkinson disease?, Lang 72(Suppl 2):S39-S43

Vascular risk factors and dementia: How to move forward?, Viswanathan et al. 72(4):368-374

Clinical Reasoning: A case of Wegener granulomatosis complicated by seizures and headaches: Curiouser and curiouser, Gorman et al. 72(3)e11-e14

Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review), England et al. 72(2):177-184

 

Neurology® 2008; Vol. 71

Identification, causation, alleviation, and prevention of complications (ICAP): An approach to symptom and disability management in multiple sclerosis, Cohen 71(Suppl 3):S14-S20

Orthostatic headache without CSF leak, Hunderfund and Mokri 71(23):1902-1906

 

Neurology® 2007; Vol. 68

Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study, Edison et al. 68(7):501-508

Education and Alzheimer disease without dementia: Support for the cognitive reserve hypothesis, Roe et al. 68(3):223-228

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease, The NINDS NET-PD Investigators 68(1):20-28

A 34-year-old man with progressive behavioral and language disturbance, Miller et al. 68(1):68-74

 

Neurology® 2006; Vol. 67

Clinical phenotype of Parkinson disease dementia, Galvin et al. 67(9):1605-1611

Relationship of vascular risk to the progression of Alzheimer disease, Regan et al. 67(8):1357-1362

Effect of a clinical stroke on the risk of dementia in a prospective cohort, Gamaldo et al. 67(8):1363-1369

 

Neurology® 2006; Vol. 66

Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Pahwa et al. 66(7):983-995